Skip to content

Insider · CIK 0002049391

Svafa Gronfeldt

director

Files at JBTM (JBT MAREL Corp). First filing -, latest -.

Svafa Gronfeldt files SEC Form 4 as director at JBTM (JBT MAREL Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Svafa Gronfeldt has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 1, 2026JBTM
JBT MAREL Corp
AGrant or award
Common Stock
+1,232$0.00$03,132Jun 3, 2026
Jun 2, 2025JBTM
JBT MAREL Corp
AGrant or award
Common Stock
+1,418$0.00$01,900Jun 4, 2025
Jan 2, 2025JBTM
JBT MAREL Corp
AGrant or award
Common Stock
+482$0.00$0482Jan 6, 2025

Questions about Svafa Gronfeldt

Answered from the filings on this page, as of the latest one.

Is Svafa Gronfeldt buying or selling?

Svafa Gronfeldt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Svafa Gronfeldt's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Svafa Gronfeldt has 0.

Where does Svafa Gronfeldt file Form 4?

Svafa Gronfeldt has filed Form 4 at JBTM (JBT MAREL Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.